Refractoriness of STING therapy is relieved by AKT inhibitor through effective vascular disruption in tumour
How STING agonists exert anti-tumour effects remains unclear. Here, the authors show that STING agonists suppress tumor growth of subcutaneous xenografts models inducing early apoptosis of endothelial cells through the TNFalpha-TNFR1 signaling, while in primary tumors, additional inhibition of AKT i...
Guardado en:
Autores principales: | Seung-hwan Jeong, Myung Jin Yang, Seunghyeok Choi, JungMo Kim, Gou Young Koh |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/f5d68f62866e4af6b7511fa91654946e |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Tumour-Not So Sweet, Tumour-Induced Hypoglycemia: A Rare Case of Refractory Hypoglycemia in a Toddler
por: Jayati Joshipura, et al.
Publicado: (2021) -
The development of tumour vascular networks
por: Anahita Fouladzadeh, et al.
Publicado: (2021) -
Disrupting tumour vasculature and recruitment of aPDL1-loaded platelets control tumour metastasis
por: Hongjun Li, et al.
Publicado: (2021) -
Clinicopathological characteristics and prognosis of gastrointestinal vascular tumours
por: Zhou Haibin, et al.
Publicado: (2021) -
Emerging role of multikinase inhibitors for refractory thyroid cancer
por: Perez CA, et al.
Publicado: (2012)